書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives影響因子(影響力)學(xué)科排名
書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives網(wǎng)絡(luò)公開度
書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives被引頻次
書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives被引頻次學(xué)科排名
書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives年度引用
書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives年度引用學(xué)科排名
書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives讀者反饋
書目名稱Antibacterial Therapy: Achievements, Problems and Future Perspectives讀者反饋學(xué)科排名
作者: 頌揚(yáng)國家 時(shí)間: 2025-3-21 22:51 作者: Intruder 時(shí)間: 2025-3-22 02:49
Prinzipien der Programmentwicklung,etic parameters: oral, parenteral, infusion, bolus injection, the amount of drug, frequency of dosing, and duration of therapy. It is questionable whether such simple calculation (MIC and concentration in the serum) can describe antimicrobial activity. The pharmacokinetic data, usually available as 作者: Merited 時(shí)間: 2025-3-22 06:11 作者: 享樂主義者 時(shí)間: 2025-3-22 12:17
Antibacterial Therapy: Achievements, Problems and Future Perspectives作者: 慢跑鞋 時(shí)間: 2025-3-22 16:11
Antibacterial Therapy: Achievements, Problems and Future Perspectives978-3-642-60803-2作者: 催眠 時(shí)間: 2025-3-22 21:01
Staphylococci, Nosocomial Infections, and the Magic Ring, the very beginning of the antibiotic epoch, this ring had something magical. The use of the ring by physicians resulted in the cure of many of the bacterial infections, which were the big killer diseases in medicine before the time of specific antimicrobial chemotherapy. It was thought that with th作者: 小木槌 時(shí)間: 2025-3-22 23:07
Expanding and Preserving the Utility of Quinolone Antimicrobials,was the first broad-spectrum fluoroquinolone to be used successfully to treat infections outside the genitourinary tract. The increasing problem of resistance to other classes of antimicrobial agents has contributed to the need for and value of current fluoroquinolones such as ciprofloxacin. In part作者: thyroid-hormone 時(shí)間: 2025-3-23 04:57
Pharmacodynamics of Antibiotics,etic parameters: oral, parenteral, infusion, bolus injection, the amount of drug, frequency of dosing, and duration of therapy. It is questionable whether such simple calculation (MIC and concentration in the serum) can describe antimicrobial activity. The pharmacokinetic data, usually available as 作者: osculate 時(shí)間: 2025-3-23 09:25
Pharmacoeconomic Research with Antibacterials,, especially within the pharmaceutical industry, have begun to study the economic impact of medicines on health care provision on a micro- and macroeconomic level. The new field of research, pharmacoeconomics, has grown at a tremendous rate, supplying ample evidence of the economic benefits of moder作者: 忘恩負(fù)義的人 時(shí)間: 2025-3-23 09:58
Conference proceedings 1997 Genetics in Cologne. During the following years he became fascinated by the emerging fields of molecular biology and gene technology. He worked together with the molecular gen- eticists W. Harms and M. Delbriick, who built up one of the most renowned institutes in the world, in Cologne. ‘‘An incred作者: HAWK 時(shí)間: 2025-3-23 16:23 作者: 清楚說話 時(shí)間: 2025-3-23 21:26 作者: chalice 時(shí)間: 2025-3-24 00:50
Expanding and Preserving the Utility of Quinolone Antimicrobials,ification and development of ciprofloxacin, the fluoroquinolone that opened the door to the expanded therapeutic potential of the quinolone class of antimicrobials (Wolfson and Hooper 1989; Hooper and Wolfson 1991). The first member of the quinolone class, nalidixic acid, is a naphthyridine derivati作者: 寬敞 時(shí)間: 2025-3-24 03:30 作者: 截?cái)?nbsp; 時(shí)間: 2025-3-24 08:25 作者: Subdue 時(shí)間: 2025-3-24 12:13 作者: 大吃大喝 時(shí)間: 2025-3-24 18:27
Pharmaceutical Industry at the Crossroads: Perspectives for Antibacterial Research,th drugs that are already commercially available. This, in turn, implies the detection of new targets. The need is due mainly to the emergence of “new”, often multiresistant, bacterial pathogens and to the high prevalence of antibiotic resistance. It is highly predictable that resistance will increa作者: BABY 時(shí)間: 2025-3-24 19:53 作者: Colonoscopy 時(shí)間: 2025-3-25 02:43
978-3-540-62896-5Springer-Verlag Berlin Heidelberg 1997作者: dragon 時(shí)間: 2025-3-25 05:11 作者: 熔巖 時(shí)間: 2025-3-25 08:59 作者: capillaries 時(shí)間: 2025-3-25 12:30 作者: 離開真充足 時(shí)間: 2025-3-25 16:56
Programmierstil und Programmtest, range of disciplines have developed new techniques to evaluate the impact of clinical care and medical technology. Clinicians, pharmacists, economists, epidemiologists and operations researchers have contributed to the new field of clinical economics to study how different approaches to patient car作者: mediocrity 時(shí)間: 2025-3-25 21:36
Die Programmiersprache Modula-2,ug resistance is growing and therefore, more widely recognized and discussed. The dialogue about drug resistance is no longer confined to the clinician, the seriously ill patient, or the drug company. One only need look at the popular press — newspapers, magazines, and even the tabloids — to underst作者: enormous 時(shí)間: 2025-3-26 04:04
,Konstruieren geht über Probieren,th drugs that are already commercially available. This, in turn, implies the detection of new targets. The need is due mainly to the emergence of “new”, often multiresistant, bacterial pathogens and to the high prevalence of antibiotic resistance. It is highly predictable that resistance will increa作者: 芭蕾舞女演員 時(shí)間: 2025-3-26 06:23
Bedingte Funktionsdefinitionen,β-lactam antibiotics, with a history far longer than most people imagine, date back to antiquity in Greece, China and other countries [1]. They were first documented with scientific precision by Alexander Fleming in 1929 [2], and were developed to the stage of large-scale production for clinical use by H.W. Florey and his collaborators [3].作者: 安撫 時(shí)間: 2025-3-26 09:25
,β-Lactams and Other Innovative New Approaches for Controlling Bacterial Populations,β-lactam antibiotics, with a history far longer than most people imagine, date back to antiquity in Greece, China and other countries [1]. They were first documented with scientific precision by Alexander Fleming in 1929 [2], and were developed to the stage of large-scale production for clinical use by H.W. Florey and his collaborators [3].作者: 不規(guī)則的跳動(dòng) 時(shí)間: 2025-3-26 13:18 作者: vibrant 時(shí)間: 2025-3-26 20:52
Conference proceedings 1997ibutions and involvement in antibacterial drug research and develop- ment within Bayer AG. In 1963 Dr. Metzger was the first "molecular micro- biologist" to join Bayer in the field of antibacterial research. Karl-Georg Metzger studied physics and biology at the University of Mainz from 1950 to 1953 作者: 泛濫 時(shí)間: 2025-3-26 22:41 作者: dainty 時(shí)間: 2025-3-27 01:32
Die Programmiersprache Modula-2,n, the seriously ill patient, or the drug company. One only need look at the popular press — newspapers, magazines, and even the tabloids — to understand the extent of public interest and concern about the drug resistance problem.作者: 沉積物 時(shí)間: 2025-3-27 05:42 作者: 積習(xí)難改 時(shí)間: 2025-3-27 13:12 作者: aesthetic 時(shí)間: 2025-3-27 15:25
Pharmaceutical Industry at the Crossroads: Perspectives for Antibacterial Research,i) resistant than to be (highly) pathogenic. Another consequence of this deterioration is that the new antibiotics have to be bactericidal; combinations can rarely be used against multiresistant clinical isolates, since most often one of the components is inactive.作者: 說不出 時(shí)間: 2025-3-27 19:22
9樓作者: Entirety 時(shí)間: 2025-3-28 01:37
9樓作者: defuse 時(shí)間: 2025-3-28 02:52
10樓作者: 鎮(zhèn)痛劑 時(shí)間: 2025-3-28 07:53
10樓作者: BRACE 時(shí)間: 2025-3-28 13:41
10樓作者: 抗原 時(shí)間: 2025-3-28 17:14
10樓
